JP2002512685A5 - - Google Patents

Download PDF

Info

Publication number
JP2002512685A5
JP2002512685A5 JP1998534532A JP53453298A JP2002512685A5 JP 2002512685 A5 JP2002512685 A5 JP 2002512685A5 JP 1998534532 A JP1998534532 A JP 1998534532A JP 53453298 A JP53453298 A JP 53453298A JP 2002512685 A5 JP2002512685 A5 JP 2002512685A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998534532A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002512685A (ja
Filing date
Publication date
Priority claimed from US08/784,857 external-priority patent/US5830918A/en
Priority claimed from US08/784,854 external-priority patent/US5851988A/en
Priority claimed from US08/916,088 external-priority patent/US6329431B1/en
Application filed filed Critical
Priority claimed from PCT/US1998/000801 external-priority patent/WO1998032017A2/en
Publication of JP2002512685A publication Critical patent/JP2002512685A/ja
Publication of JP2002512685A5 publication Critical patent/JP2002512685A5/ja
Ceased legal-status Critical Current

Links

JP53453298A 1997-01-15 1998-01-15 インスリン受容体活性のモジュレーター Ceased JP2002512685A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US78485597A 1997-01-15 1997-01-15
US08/784,857 US5830918A (en) 1997-01-15 1997-01-15 Nonpeptide insulin receptor agonists
US08/784,854 US5851988A (en) 1997-01-15 1997-01-15 Nonpeptide insulin receptor agonists
US82526997A 1997-03-27 1997-03-27
US08/784,857 1997-08-21
US08/916,088 US6329431B1 (en) 1997-01-15 1997-08-21 Nonpeptide insulin receptor agonists
US08/784,854 1997-08-21
US08/916,088 1997-08-21
US08/825,269 1997-08-21
US08/784,855 1997-08-21
PCT/US1998/000801 WO1998032017A2 (en) 1997-01-15 1998-01-15 Modulators of insulin receptor activity

Publications (2)

Publication Number Publication Date
JP2002512685A JP2002512685A (ja) 2002-04-23
JP2002512685A5 true JP2002512685A5 (enExample) 2005-09-08

Family

ID=27542207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53453298A Ceased JP2002512685A (ja) 1997-01-15 1998-01-15 インスリン受容体活性のモジュレーター

Country Status (9)

Country Link
EP (1) EP0960335B1 (enExample)
JP (1) JP2002512685A (enExample)
AT (1) ATE296446T1 (enExample)
AU (1) AU6026698A (enExample)
CA (1) CA2278023A1 (enExample)
DE (1) DE69830301T2 (enExample)
DK (1) DK0960335T3 (enExample)
ES (1) ES2242995T3 (enExample)
WO (1) WO1998032017A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875741B2 (en) * 1998-09-02 2005-04-05 Renuka Pillutla Insulin and IGF-1 receptor agonists and antagonists
EP1115847A1 (en) 1998-09-25 2001-07-18 Children's Medical Center Corporation Short peptides which selectively modulate the activity of protein kinases
TWI234557B (en) * 1999-05-26 2005-06-21 Telik Inc Novel naphthalene ureas as glucose uptake enhancers
US7181349B1 (en) * 1999-05-27 2007-02-20 Cecil Yip Identification of compounds for modulating dimeric receptors
ITTO20000745A1 (it) * 1999-07-29 2002-01-28 Telik Inc Nuovi acidi naftilsolfonici e composti ad essi correlati utli come agonisti dell'assorbimento del glucosio.
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
EP1383793B1 (en) * 2000-03-29 2011-10-19 DGI BioTechnologies, L.L.C. Insulin and igf-1 receptor agonists and antagonists
WO2002055664A2 (en) * 2001-01-12 2002-07-18 Exelixis, Inc. Modulating insulin receptor signaling
CN101103977A (zh) * 2002-06-05 2008-01-16 株式会社医药分子设计研究所 糖尿病治疗药
TW200410671A (en) * 2002-06-05 2004-07-01 Inst Med Molecular Design Inc Medicines for inhibiting the activation of AP-1
CN1658855B (zh) 2002-06-06 2010-04-28 株式会社医药分子设计研究所 O-取代羟基芳基衍生物
CN1658872B (zh) * 2002-06-06 2010-09-22 株式会社医药分子设计研究所 抗过敏药
EP1535610A4 (en) * 2002-06-10 2008-12-31 Inst Med Molecular Design Inc THERAPEUTIC CANCER
EA010470B1 (ru) * 2002-06-10 2008-08-29 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. ИНГИБИТОРЫ АКТИВАЦИИ NF-kB
DE10323081A1 (de) * 2003-05-22 2004-12-16 Aventis Pharma Deutschland Gmbh Verwendung eines Polypeptides
JP2008542685A (ja) * 2005-05-05 2008-11-27 ヴァロリザーシヨン・アッシュエスジ,ソシエテ・アン・コマンディット サイトカイン受容体修飾因子及びその使用
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023231A1 (en) * 1994-02-28 1995-08-31 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Cell lines for the identification of substances affecting insulin receptor mediated signal transduction
WO1996030762A1 (en) * 1995-03-31 1996-10-03 Merck & Co., Inc. Insulin mimetic and enhancer assay

Similar Documents

Publication Publication Date Title
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000509912A5 (enExample)
JP2000509635A5 (enExample)
JP2000509637A5 (enExample)
JP2001526586A5 (enExample)
JP2001521503A5 (enExample)
JP2001524003A5 (enExample)
JP2002508713A5 (enExample)
JP2000509587A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508841A5 (enExample)
JP2000517086A5 (enExample)
JP2001522270A5 (enExample)
JP2001517314A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2002500763A5 (enExample)
JP2000510247A5 (enExample)
JP2000508836A5 (enExample)
JP2001526655A5 (enExample)
JP2000509818A5 (enExample)